Report overview
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
This report aims to provide a comprehensive presentation of the global market for Gene Delivery or Gene Therapy Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Delivery or Gene Therapy Drug. This report contains market size and forecasts of Gene Delivery or Gene Therapy Drug in global, including the following market information:
Global Gene Delivery or Gene Therapy Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Gene Delivery or Gene Therapy Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Viral Gene Delivery System Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gene Delivery or Gene Therapy Drug include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and Sunway Biotech, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gene Delivery or Gene Therapy Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Delivery or Gene Therapy Drug Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Gene Delivery or Gene Therapy Drug Market Segment Percentages, by Type, 2022 (%)
Viral Gene Delivery System
Non-viral Gene Delivery System
Global Gene Delivery or Gene Therapy Drug Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Gene Delivery or Gene Therapy Drug Market Segment Percentages, by Application, 2022 (%)
Neurological Diseases
Cancer
Other
Global Gene Delivery or Gene Therapy Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Gene Delivery or Gene Therapy Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene Delivery or Gene Therapy Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gene Delivery or Gene Therapy Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gene Delivery or Gene Therapy Drug, market overview.
Chapter 2: Global Gene Delivery or Gene Therapy Drug market size in revenue.
Chapter 3: Detailed analysis of Gene Delivery or Gene Therapy Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gene Delivery or Gene Therapy Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
